
Pfizer, BioNTech Lose Appeal in COVID–19 Vaccine Patent Battle With Moderna
The London Court of Appeal upheld an earlier court decision in the long–running battle between the global pharma firms.

The London Court of Appeal upheld an earlier court decision in the long–running battle between the global pharma firms.

Following increasing reports of quality control issues in batches of vaccines, as well as adverse effects, a group of chemistry professors expressed their concerns in an open letter to Germany’s control authority.